Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.
Data sharing capabilities with connected devices allows for more efficient and timely insulin dosing recommendations. AJMC interviews Robby Booth, Senior Vice President Research & Development at Glytec.
Use of Glucommander for management and resolution of diabetic ketoacidosis in hospitalized patients. MedPage Today interviews Dr. Guillermo Umpierrez.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, operations perspective. Audrey Douglas-Cooke, Vice President Operations and Associate Nursing Executive.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, executive perspective. Dr. Paul Chidester, Vice President Medical Affairs, and Dr. H. Courtenay Harrison, Jr., Medical Director Diabetes Center.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, nursing perspective. Margaret Bachand, Diabetes Center Manager; Evelyn Olenick, Vice President Patient Care Services; and Grace Pagtakhan, former Clinical Nurse II.
Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.
How eGMS enables subcutaneous basal bolus insulin therapy and overcomes difficulties of meal-to-meal dosing adjustments. MD Magazine interviews Dr. Jagdeesh Ullal.
DECEMBER 21, 2015Closing the glucose gaps in hospital diabetes care. Managing editor, diabetes advocate and person with type 1 diabetes, Mike Hoskins.Mike Hoskins, a person living with type 1 diabetes and Managing Editor of DiabetesMine (web log focused on diabetes advocacy), delivers straight talk on the state of inpatient diabetes care and the role of Glytec’s solutions in quality improvement …